<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04923425</url>
  </required_header>
  <id_info>
    <org_study_id>18936 CairoU</org_study_id>
    <nct_id>NCT04923425</nct_id>
  </id_info>
  <brief_title>Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy</brief_title>
  <official_title>Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy. A Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identify possible modulators for developing gustatory dysfunction among a sample of depressed&#xD;
      Egyptian adults (age from 20 to 50 years old) under anti-depressants therapy ( for at least 3&#xD;
      months) using a questionnaire ( appendix) with a binary measuring unit (yes/no).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PECO&#xD;
&#xD;
        -  P Population: depressed Egyptian adults under anti-depressants therapy&#xD;
&#xD;
        -  E1 Exposure 1: commonly prescribed tricyclic antidepressants (Imipramine, Amitriptyline,&#xD;
           Clomipramine HCL)&#xD;
&#xD;
        -  E2 Exposure 2: commonly prescribed Selective Serotonin Re-uptake inhibitors&#xD;
           antidepressants ( Fluoxetine, Fluvoxamine, Sertraline, Citalopram, Paroxetine)&#xD;
&#xD;
        -  C control (non exposure) : non-pharmacological treatment ( psychotherapy)&#xD;
&#xD;
        -  O Outcome: Identify possible gustatory dysfunction modulators among these patients using&#xD;
           a questionnaire ( appendix) with a binary measuring unit (yes/no).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 22, 2020</start_date>
  <completion_date type="Actual">October 7, 2020</completion_date>
  <primary_completion_date type="Actual">August 8, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gustatory dysfunction modulators</measure>
    <time_frame>during a period of 7months from February 2020 till August 2020</time_frame>
    <description>-C.M will use an assessment questionnaire (appendix) to assess possible modulators for developing gustatory dysfunction including a number of short-term and long-term factors such as body mass, gender, age, local and systemic diseases, excessive alcohol drinking, drug dependence, smoking, state of oral hygiene, consumption of some foods or drugs</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Taste Disorders</condition>
  <arm_group>
    <arm_group_label>Exposure 1</arm_group_label>
    <description>commonly prescribed tricyclic antidepressants (Imipramine, Amitriptyline, Clomipramine HCL) administered for at least 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exposure 2</arm_group_label>
    <description>commonly prescribed Selective Serotonin Re-uptake inhibitors antidepressants ( Fluoxetine, Fluvoxamine, Sertraline, Citalopram, Paroxetine) administered for at least 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non exposure</arm_group_label>
    <description>Non-pharmacological treatment (psychotherapy)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Depressed Egyptian adults under anti-depressants therapy The patients will be recalled&#xD;
        using their phone numbers recorded in their follow up records in order to come to the&#xD;
        Diagnosis center at the faculty of Dentistry, Cairo University to be assessed for possible&#xD;
        gustatory dysfunction modulators and will be given identification numbers and divided into&#xD;
        three groups, to which the operator shall be blinded.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Depressed Egyptian adults under antidepressants therapy for at least 3&#xD;
             months/non-pharmacological treatment( psychotherapy)&#xD;
&#xD;
               -  Age from 20 to 50 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Antipsychotics&#xD;
&#xD;
               -  Hypnotics&#xD;
&#xD;
               -  Anticonvulsants&#xD;
&#xD;
               -  Ages other than the mentioned • Olfactory dysfunction&#xD;
&#xD;
               -  Chemosensory dysfunction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Dentistry, Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 6, 2021</study_first_submitted>
  <study_first_submitted_qc>June 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>June 13, 2021</last_update_submitted>
  <last_update_submitted_qc>June 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Christine Raouf George Mikhail</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Taste Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

